Our own early (unpublished) analysis depicted in Figure 1b revealed differences between Chk2 activation in CML and PV, suggesting differences in functions of its upstream regulator ATM kinase. The gene discussed is CHEK2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.